Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension
- RxCUI
- 1251365
- RxNorm name
- Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension
- Display name
- Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension
- Full name
- Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GAVISCON | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | Haleon US Holdings LLC | 2d74e5bc-1f10-4fb6-9258-cd906e360013 | 2026-02-13 | Warnings | 1251365 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2d74e5bc-1f10-4fb6-9258-cd906e360013 | Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension [PSN] · aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon] [SBD] · Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension [SY] · Gaviscon (aluminum hydroxide 95 MG / magnesium carbonate 358 MG) per 15 ML Oral Suspension [SY] | 4 | 23 | Drug Facts | 20260213 |